Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Multiwave Technologies | 2025 | Venture - Series Unknown | $4.5M | Geneva |
| Veezoo | 2025 | Series A | $6.0M | Zürich |
| Cutiss | 2025 | Series C | $38.9M | Zürich |
| Cellvie | 2025 | Seed | $5.0M | Houston |
| Manukai | 2025 | Pre-Seed | $3.0M | Zurich |
| machineMD | 2025 | Venture - Series Unknown | Undisclosed | Bern |
| MPower Ventures | 2025 | Venture - Series Unknown | $2.7M | Zúrich |
| Akina | 2025 | Seed | $3.2M | Zúrich |
| Embotech | 2024 | Series B | $26.3M | Zúrich |
| Lyfegen | 2024 | Series A | $5.7M | Basel |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 76 | Multiwave Technologies | Venture - Series Unknown | $4.5M | Geneva, Switzerland |
| 77 | Veezoo | Series A | $6.0M | Zürich, Switzerland |
| 78 | Cutiss | Series C | $38.9M | Zürich, Switzerland |
| 79 | Cellvie | Seed | $5.0M | Houston, United States |
| 80 | Manukai | Pre-Seed | $3.0M | Zurich, Switzerland |
| 81 | machineMD | Venture - Series Unknown | Undisclosed | Bern, Switzerland |
| 82 | MPower Ventures | Venture - Series Unknown | $2.7M | Zúrich, Switzerland |
| 83 | Akina | Seed | $3.2M | Zúrich, Switzerland |
| 84 | Embotech | Series B | $26.3M | Zúrich, Switzerland |
| 85 | Lyfegen | Series A | $5.7M | Basel, Switzerland |
Multiwave is a deep tech company developing disruptive medical imaging devices
Veezoo is a software company that develops analytics solution for business insights from cloud databases using natural-language.
Cutiss is a life science company that engages in regenerative medicine production, skin tissue engineering, and curated therapy solutions.
Cellvie develops cell-derived medicines, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell.
Manukai, an ETH Zurich spin-off, creates novel AI models to unlock the value of production data in metal machining.
machineMD combines virtual reality and artificial intelligence into a medical device for the early diagnosis of neurological disorders
MPower Ventures is a technology company that offers funding, software, and solar products to facilitate energy access in emerging markets.
Akina provides AI-enabled connected therapy for patients with musculoskeletal conditions.
Embotech is an IT consulting firm that provides autonomous driving solutions for industrial logistics applications.
Lyfegen is SaaS company that develops rebate management software for the healthcare industry.
An Innovation Engine In Sports Medicine
Neustark is a concrete producer in bern using wastewater treatment plant by turning CO2 into minerals.
LEDCity is a energy technology company that designs and develops efficient lighting systems for commercial buildings.
Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.
Volumina Medical is a healthcare technology company that engages develops injectable 3D scaffolds for the reconstruction of soft tissues.
TissueLabs is a biotechnology research company that operates a platform for creating organs and tissues in the lab.
Galventa provides pharmaceutical manufacturing services for a micro-pellet-based food supplement that relieves sleep inertia symptoms.
True precision medicine through single-cell science
Atinary is an end-to-end AI, machine learning, robotics, and cloud computing technology platform for digitizing R&D operations.
Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices.
OptiChroniX is a Swiss Digital Health Solutions company dedicated to improving brain health early.
PIPRA is developing a cutting-edge AI-based pre-surgical tool to assess patients' risk of suffering from cognitive impairment after surgery.
Accelerate computational medical XR
Sparkli is an AI-driven learning platform for kids aged 5–12 that turns curiosity into multimodal educational experiences.
Distran is a spin-off from the Autonomous System Lab, ETH Zurich, developing advanced acoustic sensors for industrial applications.
Innosuisse has invested in 211 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Innosuisse's top investment sectors include Health Care, Medical Device, Software, Biotechnology, Medical. The firm invests across 49 different industry categories.
Among tracked funding rounds, Neustark received $69.0M in a Venture - Series Unknown round. Innosuisse's total known invested capital is $569.8M.
Innosuisse's average investment size is $3.2M across its portfolio of 211 companies.
Recent Innosuisse portfolio additions include Multiwave Technologies, Veezoo, Cutiss, Cellvie, Manukai. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors